Abstract
Objective: To investigate the clinical significance of the serum VEGF as a marker for monitoring the clinical course of tumor patients cured by surgery and radiotherapy. Methods: Enzyme linked immunosobent assay (ELISA) was used to detect serum levels of VEGF in the patients with carcinoma. Results: X-ray irradiation could induce the tumor cells to express and secret VEGF. Patients with elevated values of serum VEGF 60 days after radiotherapy had higher rate of tumor recurrence and metastasis. There was more chance of metastasis in lung cancer patients with higher level of VEGF after surgical resection (12/21). Less post-operation (3 months-4 years) patients without relapse or cancerometastasis showed elevated values of serum VEGF than those with relapse or cancerometastasis. There was negative correlation between the serum Hb and VEGF in the tumor patients (γ=−0.289, P<0.01). In the 28 patients with normal Hb levels at pre-operation, 17 patients with decreased Hb levels had more chance getting higher VEGF after operation than the others (P<0.05). Conclusion: clinical manifestation should be considered in the application of serum VEGF as a tumor marker, a prognostic factor, and a recurrence indicator of tumor. To determine the levels of serum VEGF and Hb, correct the low level of Hb and block the effect of VEGF by special means may be helpful for tumor patients.
Similar content being viewed by others
References
Ellis LM, Liu W, Wilson M. Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation[J]. Surgery 1996; 120: 871.
Asano M, Yukita A, Matsumoto T, et al. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelia growth factor/vascular permeability factor 121[J]. Cancer Res 1995; 55: 5296.
Matsuyama W, Hashiguchi T, Mizoguchi A, et al. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer[J]. Chest 2000; 118: 948.
Salven P, Ruotsalainen T, Mattson K, et al. High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer[J]. Int J Cancer 1998; 79: 144.
Ando S, Nojima K, Majima H, et al. Evidence for mRNA expression of vascular endothelial growth factor by X-ray irradiation in a lung squamous carcinoma cell line[J]. Cancer Lett 1998; 132: 75.
Molls M, Stadler P, Becker A, et al. Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels[J]. Strahlenther-Onkol 1998; 174: 413.
Maniwa Y, Okada M, Ishii N, et al. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer[J]. Chest 1998; 114: 1668.
Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease[J]. Cancer 1999; 178.
Author information
Authors and Affiliations
Corresponding author
Additional information
Foundation item: This work was supported by a grant from the Natural Science Foundation of Liaoning Province of China (No. 002032).
Biography: Xue Wen-cheng(1966–), male, master, General Hospital of Shenyang Command, majors in tumor marker.
Rights and permissions
About this article
Cite this article
Xue, Wc., Meng, Dy., Yang, J. et al. Significance of inspecting serum VEGF during therapy of tumor. Chin. J. Cancer Res. 14, 302–304 (2002). https://doi.org/10.1007/s11670-002-0066-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-002-0066-8